Glaucoma Management: Topical Agents, Sustained-release Drug Delivery Systems, and Surgical Management
Complimentary
Released on 7/21/25
Expires on 7/21/26
Take Me to the Event Registration
Program Description
This enduring webcast covers diagnostic protocols, risk stratification techniques, and pharmacologic options, with a focus on the utility and limitations of topical therapies. The curriculum highlights recent innovations in sustained-release drug delivery and reviews comparative outcomes of surgical interventions. Expert insights are provided by renowned faculty from leading academic institutions, offering practical guidance for personalized treatment planning. Learners will gain access to evidence-based approaches and clinical trial data supporting emerging management strategies. Designed for ophthalmologists and optometrists seeking to enhance therapeutic decision-making and optimize patient care.
Intended Audience
Ophthalmologists, optometrists, advanced practice providers (physician assistants and nurse practitioners), and nurses who manage patients with glaucoma.
Commercial Supporter
Supported by an unrestricted educational grant from Alcon Vision, LLC.
Learning Objectives
Upon completion of the educational activity, participants should be able to:
- Summarize the pathophysiology, clinical presentation, risk factors, and the role of topical agents in managing glaucoma
- Analyze the clinical trial data on sustained-release drug delivery systems and surgical approaches to manage glaucoma.
Accredited Providers
This activity is jointly provided by Haymarket Medical Education and MedNet.


Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Haymarket Medical Education and MedNet. Haymarket Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians Credit Designation
Haymarket Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses Credit Designation
This activity is awarded 1.25 contact hours (based on 60 minutes per contact hour).
Additional Credit Information
Note to Physician Assistants
AAPA accepts AMA PRA Category 1 CreditTM for the PRA from organizations accredited by ACCME. Maximum of 1.25 hours.
Note to Nurse Practitioners
The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors, and allows reciprocity for AANPCP continuing education credit. Maximum of 1.25 hours.
Through an agreement between the American Medical Association (AMA) and the European Union of Medical Specialists, physicians and healthcare providers may convert AMA PRA Category 1 CreditsTM to an equivalent number of European CME Credits® (ECMECs®). The UEMS-EACCME® has recognition agreements with the AMA for live events and e-learning materials.
Conflicts of Interest Disclosure Policy
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Haymarket Medical Education and MedNet require that individuals in a position to control the content of an educational activity disclose all financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. HME and MedNet mitigate all reported relevant financial relationships to ensure independence, objectivity, balance, and scientific rigor in all its educational activities.
Accredited Provider Disclosures
Haymarket Medical Education staff have no relevant financial relationships to disclose.
Planners’ and Managers’ Disclosures
MedNet staff have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a clinician relative to diagnostic and treatment options for a specific patient’s medical condition.
Disclaimer
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Haymarket Medical Education, MedNet, or Alcon Vision, LLC. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
If you have any questions relating to the accreditation of this activity, please contact cme.questions@haymarketmedical.com

Robert J. Noecker, MD
Assistant Clinical Professor of Ophthalmology
Yale University School of Medicine
New Haven, CT
Clinical Professor of Surgery at the Frank Netter School of Medicine of Quinnipiac University
North Haven, CT
Dr. Noecker has nothing to disclose.

Walter Whitley, OD, MBA, FAAO
Director of Professional Relations and Education
Virginia Eye Consultants
Regional Medical Director
Eyecare Partners
Norfolk, VA
Dr. Whitley discloses that he is an Advisory Board Member for: Alcon, Allergan, Bausch and Lomb, Bruder Healthcare, Science Based Health, Sun Pharmaceuticals, Tarsus Pharmaceuticals, Visus Pharmaceuticals. Consultant for: Alcon, Aldeyra Therapeutics, Allergan, Apellis Pharmaceuticals, CSI Dry Eye Inc., Epion, Glaukos, Harrow, 12-Vision, Inc., Iveric Bio, Mediprint Pharma, Nordic Pharma, OD Immersion, Regener-Eyes, Sight Sciences, Thea Pharmaceuticals, Trukera, Viatris. Speaker for: Alcon, Allergan, Apellis Pharmaceuticals, Bausch and Lomb.
All of the relevant financial relationships listed for this individual has been mitigated.
Instructions
In order to receive CME/CE credits, participants must complete the pre-assessment questions, post-assessment, and program evaluation. Participants must also score at least 75% on the post-assessment. Certificates will be distributed online at the conclusion of the activity. Your online certificate will be saved on myCME within your Dashboard or Transcript, which you can access at any time.
Related products
-

MGD-Associated Dry Eye Disease: Pathophysiology, Current and Emerging Therapies for Improved Outcomes
Read more -

Sustained-Release Drug Delivery System in the Management of Glaucoma
Read more -

New Paradigms in the Management of Hereditary Transthyretin Amyloidosis Mixed Phenotype (ATTRv): ATTRv-CM and ATTRv-PN
Read more -

Emerging Strategies in the Diagnosis and Treatment of Amyotrophic Lateral Sclerosis
Read more




